Introduction
Mononuclear phagocytes are mobile, long-lived cells of bone marrow origin that form a resident population in many tissues of the body and play central roles as effector cells in inflammatory reactions and cell-mediated immune responses (1, 2) . Some examples are alveolar macrophages in the lung, Kuppfer cells in the liver, sinus histiocytes in the spleen, and microglia in the central nervous system (CNS). In response to external stimuli resident macrophages become "activated" (3) . Inflammation, wound healing, and host defense against microbes or tumors represent scenarios in which activated resident macrophages and blood-borne monocytes, which are recruited into the tissue and differentiate, can influence the structure and composition of their environment.
Macrophage activation is a complex, multistep process that ultimately results in enhanced ability of the macrophage to phagocytose and kill foreign cells (2, 4) . Activation (3, 4) . Secreted acid hydrolases are derived from a preformed store contained in lysosomes, and are released rapidly, frequently within 4-6 hr after exposure to activating agents, while the release of neutral proteinases (elastase, plasminogen activators) is usually delayed for 24 hr (3). Although the aspartyl proteinase cathepsin D has been well studied during macrophage activation, the role of released cysteine lysosomal cathepsins upon macrophage and microglial activation is relatively unknown.
The cysteine lysosomal proteases include cathepsins B, L, H, S, 0, and K. Of these, only cathepsin S retains activity after prolonged incubation at neutral pH, whereas all the others become irreversibly inactivated (5) (6) (7) . It is this fact that makes cathepsin S unique and a good candidate for tissue destruction and remodeling of the ECM in nonacidic extracellular environments (8) . It has been demonstrated previously that cathepsin S is able to degrade a number of components of ECM (9) (10) (11) (12) . We and others have previously demonstrated that cathepsin S expression is highly restricted to cells of the mononuclear-phagocytic system, including microglia (11) (12) (13) .
Here we examine the regulation of cathepsin S at the mRNA and protein level, in macrophages and microglia, by inflammatory mediators, as well as the regulation of cathepsin B and L mRNAs. We demonstrate that the expression of cathepsin S, cathepsin B, and cathepsin L mRNAs, and cathepsin S activity are regulated by lipopolysaccharide and cytokines. In addition, we show that Perlecan, a basement membrane heparan sulfate proteoglycan (HSPG), can be degraded by cathepsin S in vitro. Heparan sulfate proteoglycans, including those of the basement membrane, can serve many functions, e.g., adhesion, as a binding site for proteases, and regulation of growth factors such as basic fibroblast growth factor (bFGF) (14) (15) (16) (17), and equal amounts of each extract were analyzed by Western blotting as described previously (17) . Signals were detected either by iodinated protein A (0.2 mCi/ml of '251-protein A) or by enhanced chemiluminescence (DuPont NEN). Specific bands were quantified by phosphorimager.
Cathepsin S Activity Determination Enzymatic assays were performed as previously described (11) with modification. Conditioned media (C.M.) were collected from treated cells, centrifuged at 16,000 X g for 1 min, transferred to new tubes, and frozen at -20°C until use. Cells were lysed in 200 ml of 10 mM sodium acetate buffer pH 5.5, 2 mM EDTA, 0.01% Triton X-100, 1 ,M PMSF, and 5 ,tM pepstatin A, collected with a rubber scraper, and frozen at -20°C until use. The lysates were subjected to a neutral pH incubation step prior to cathepsin-S activity determination; this step has been shown to inactivate other lysosomal proteases with substrate specificity similar to that of cathepsin S (7, 9) . For this, lysates (10%) were sonicated and then incubated with neutral pH buffer (0.1 M Tris-Cl, pH 7.5, 2 mM EDTA, 2 mM DTT, 0.01% Triton X-100, 1 5 ,tM pepstatin A, and 0.01% Triton X-100 at 2 5°C. For proteoglycan digestion, 1 or 2 ,ug of heparan sulfate proteoglycan (HSPG; Collaborative Biomedical Products, Bedford, MA) was incubated with recombinant human cathepsin S in the above sodium phosphate buffer including inhibitors at either pH 6.5, or pH 7.5, with or without E64 at 37°C for 2.5 hr or 1.5 hr. Following termination of the reaction by an excess of E64, some reaction mixtures were subjected to heparitinase (Sigma) treatment, were heated at 950C for 5 min, and resolved on SDS polyacrylamide gels and visualized by silver staining.
Ligand Blotting of Cell-Derived HSPGs Wild-type and transfected BAE cells were plated at 6 X 105 cell/35-mm dish for 24 hr, washed three times with PBS, and pretreated with activated cathepsin S (see above) in PBS for 3 hr on a shaker at 250C. Following pretreatment, the cells appeared viable under the light microscope and none were detached. The cells were lysed in PB S containing 1 % Triton X-100 containing 2% glycerol, 0.1 ,ug/ml aprotinin, 0.1 ,ug/ml leupeptin, and 20 mM EDTA. Proteins were separated by SDS-PAGE on 3-15% gels, transferred to polyvinylidene difluoride (PVDF) membranes by wet-transfer method utilizing 0.1% SDS in the buffer, and blots were incubated in BLOTTO with 1 ,g/ml of '251-bFGF, with or without 10 ,ug/ml of heparin, for 12 hr at 40C. Blots were washed of unbound ligand using PBS and PBS-Tween 20 and exposed to phosphorimager screens.
Expression of Cathepsin S in Cell Lines
Cells were stably transfected with the full-length rat cathepsin S cDNA (21) in a mammalian expression vector, pcDNA3 (Invitrogen, Carlsbad, CA) using Lipofectamine reagent (Gibco BRL) according to manufacturer's instructions.
Cell Attachment Assays Determination of 32D-FGFR-1 cells' bFGF-dependent attachment to an adherent layer was performed as previously described (18 
Results
We have previously shown that cathepsin S mRNA exhibits restricted distribution and is expressed in different populations of macrophages in the periphery and in microglia in the brain (11, 20, 21) . Consistent with this is the finding that cathepsin S expression has been demonstrated in alveolar macrophages and in monocyte-derived macrophages after differentiation (12, 22) . Cathepsin S is not expressed in other glial cells, such as type 1 astrocytes or 02A progenitors, nor in neuronal cell lines, whereas cathepsin B and L are widely expressed (20) .
To examine if other blood-derived cells express cathepsin S, we performed Northern analysis on total RNA from various cell lines. Of the cell lines tested (macrophage, RAW 264.7; microglial, N13; monocytic, HL60, U937, WEHI, KG-1 and THP-1; erythro-megakaryo-granulo-cytic, K562; and megakaryocytic, DAMI) we found cathepsin S expression only in the macrophage, RAW 264.7, and in the microglial, N13, cell lines as a 1.4 kB mRNA (Fig. IA) Fig. 2A, B) . The levels of cathepsin B mRNA were decreased by LPS in macrophages and microglia to 18% and 50%, respectively ( Fig. 2A, B) . Treatment of microglia with 100 ng/ml of LPS decreased cathepsin L mRNA to 21% that of untreated cells (data not shown). Examination of the time course of cathepsin S, cathepsin B, and cathepsin L mRNA regulation by 30 ng/ml of LPS in RAW 264.7 macrophages showed that within 4 hr of LPS treatment, there is a substantial decrease in all three mRNAs to about 30% that of control treatments (MSFM without LPS) (Fig. 3) . After 8 hr of LPS treatment, compared to control treatments, the cathepsin mRNAs remained at a low level. LPS had a similar effect on rat primary alveolar macrophages; it led to a decrease in cathepsin S (Fig. 4A) We were interested in the effect of other activators of macrophages and microglia, such as the cytokines produced and released by activated macrophages/microglia themselves and/or other stimulated cells during an inflammatory process, on the expression of cathepsin S, cathepsin B, and cathepsin L mRNAs. We found that TNF-a, IL-la, IFN-,y, GM-CSF, IFN-a, and PMA decreased the levels of all three transcripts in microglia after 24 hr of treatment (Table 1) , which is similar to the effect of LPS.
To examine if the decrease in mRNA levels for cathepsin S Following SDS-PAGE of cell lysates or recombinant cathepsins, Western blotting was performed with anti-cathepsin S antiserum as described in Materials and Methods. In the graphs, relative intensity in the absence of treatment is taken as control (100%). Data represent mean ± SEM of three experiments for RAW cells and mean ± SEM of two experiments for N1 3 cells.
active-site cysteine protease inhibitor, E64, as an indication of specificity to enable us to determine cysteine protease activity. We also used preincubation of samples at neutral pH to specifically A. determine cathepsin S activity, since other cysteine lysosomal proteinases become irreversibly inactivated after prolonged incubation at neutral pH (7, 9) . Just as LPS had decreased mRNA expression, LPS decreased the levels of cathepsin S protease activity in both RAW and N1 3 cells in a dose-dependent manner (Fig. 6A, B) . A 50% decrease in cellular cathepsin S activity was achieved in RAW macrophages and N1 3 microglia by LPS at 30 ng/ml and 3 ng/ml, respectively. Cathepsin S activity decreased by >75% in response to 300 ng/ml of LPS in both RAW and N1 3 cells. Similarly, 24-hr treatment with PMA, TNF-a, IFN--y, IL-la, IFN-a, and GM-CSF dramatically decreased the levels of cellular cathepsin S activity in RAW and N13 cells (Fig. 6C, D) ; this is consistent with the observed decrease in levels of cathepsin S mRNA by these agents. In contrast to the decreased level of cathepsin S activity in cells, we found that LPS dosedependently increased secreted cathepsin S activity from RAW or N13 cells (Fig. 7A, B) . A low concentration of 3 ng/ml LPS increased cathepsin S activity to about 1.8 times control levels in A. RAW-conditioned medium and to about 2.1 times control levels in N13-conditioned medium following 24-hr treatment. LPS at 300 ng/ml increased cathepsin S activity 2.7-fold in RAWand 3.1-fold in N13-conditioned medium. Also, we found that the agent PMA and the cytokines TNF-a, IFN-y, IL-la, IFN-a, and GM-CSF increased the levels of cathepsin S protease activity found in the culture medium of RAW macrophages and N 13 microglia by [2] [3] times that of control levels after 24-hr treatment (Fig. 7C, D) . On the other hand, treatment of cells for 24 hr with TGF-f3, an inhibitor of macrophage activation, did not result in increased secretion of cathepsin S activity (J. P. Liuzzo and L. A. Devi, unpublished observations). We also followed the time course of cathepsin S secretion and cellular activity in RAW macrophages and NI 3 microglia. Cells initially cultured in MSFM for 24 hr were then treated with 30 ng/ml of LPS in fresh MSFM for various durations. LPS decreased the cellular levels of cathepsin S activity in RAW macrophages to about 50% of the control level after 2 hr of treatment (Fig. 8A ). In the conditioned medium it was found that LPS rapidly caused the secretion of cathepsin S activity, which was evident after 15 min (Fig. 8B) . Since the cathepsin S mRNA and cellular activity were decreased after 24 hr of treatment with activating agents, cathepsin S activity present in macrophage and microglia C.M. at 24 hr is likely the result of stability at neutral pH of this rapidly secreted protease. However, we cannot exclude the possibility that a yet-unidentified cysteine lysosomal protease with similar properties contributes to the observed secreted activity. These data suggest that macrophages and microglia, upon activation by cytokines, secrete a cathepsin S-like activity, A.
B. which in turn may take part in the dissolution of the ECM and its remodeling. We have previously demonstrated that cathepsin S processes two brain chondroitin proteoglycans, neurocan and phosphacan (11) , and the amyloid precursor protein (S. S. Petanceska and L. A. Devi, unpublished observations), which is known to contain chondroitin sulfate modifications (26, 27) . We investigated whether recombinant cathepsin S can cleave basement membrane HSPG. Following a 2.5-hr incubation at pH 6.5 of recombinant human cathepsin S, purified basement membrane HSPG was almost completely degraded (Fig. 9A) . Including E64 in the reaction mixture completely abolished the degradation of the HSPG. We also compared the ability of cathepsin S to degrade basement membrane HSPG at a neutral pH and found that cathepsin S degraded basement membrane HSPG at both pH 6.5 and pH 7.5 with similar efficiencies (Fig. 9B) .
We tested whether exogenous recombinant cathepsin S could affect the binding of iodinated bFGF ('251-bFGF) to cells and affect the bFGFdependent adhesion of 32D-FGFR cells to CHO cells in co-culture experiments (17, 18) , and found that exogenous recombinant cathepsin S did not decrease the bFGF-dependent adhesion between these two cell types (data not shown). To overcome the possibility that exogenous cathepsin S is being inhibited by cell surface inhibitors, we overexpressed cathepsin S in cells and examined the effect on cell-derived HSPGs. We transfected CHO Transfected, adherent CHO and BAE cells were then used in co-culture experiments to determine the effect on bFGF-dependent attachment of 32D-FGFR-1 cells to HSPGs (18) . Attachment of 32D-FGFR-1 cells to wild-type and cathepsin S-transfected CHO cells and BAE cells revealed a 10% to 20% decrease in bFGF-dependent attachment (Fig. 1OA) . This decreased attachment could be inhibited by culturing the adherent cell layer in the presence of the specific, cysteine lysosomal protease inhibitor, E64 (Fig. lOB) (1,4,33) .
The cysteine proteinases of the cathepsin family are able to degrade a wide range of protein substrates, thus their localization in lysosomes exemplifies their role in protein turnover (34) . They have also been demonstrated to function in degradation of the major proteins found in the ECM and basement membranes. Specifically, cathepsin B is found to degrade collagens (including type IV), proteoglycans, laminin, and fibronectin (35) (36) (37) (38) and cathepsin L is found to degrade collagen, elastin, fibronectin, and laminin (39) (40) (41) in vitro at acidic pH. We and others have demonstrated that cathepsin S has the ability to degrade laminin, fibronectin, collagens, elastin, and chondroitin sulfate proteoglycan (CSPG) at both neutral and acidic pH (9) (10) (11) (12) . Therefore, cathepsin S may function extracellularly for long durations to proteolyse proteins of the interstitial matrix.
Macrophage recruitment during immune and inflammatory processes requires adhesion to endothelium, extravasation through the vessel wall, and migration into the appropriate tissue. This process, which mimics tumor cell metastasis, requires proteases to degrade the ECM and the basement membrane surrounding blood vessels (42) . For a role of cysteine proteinases in macrophage degradation of ECM and basement membrane components during inflammation it is important to demonstrate extracellular active forms of these enzymes. Cathepsin B is secreted from malignant tumors in an active high-molecular-weight form that is stable at neutral pH and this correlates with metastatic potential (43) . Cathepsin L precursors are also found extracellularly via secretion from transformed and nontransformed fibroblasts, but is inactive at neutral pH and becomes an active enzyme only at pH 3.0 (34, 44) . Since secreted precursor cathepsin L is inactive at neutral pH and precursor cathepsin B is active but secreted only from malignant cells, our demonstration of increased secreted active cathepsin S from stimulated cells of the mononuclear-phagocytic system suggests that cathepsin S could contribute substantially to the extracellular degradation. Alternatively, the increase in extracellular cathepsin S-like activity can be due to down-regulation of the constitutive secretion of cystatin C, as observed in activated monocytes and macrophages (45) .
Macrophages and microglia secrete well over 100 products when activated, and this complex process must be highly regulated by external stimuli of both microbial and mammalian origin (3, 4) . LPS is a potent stimulant for macrophages and microglia and in high concentrations may result in a full activation state. The proinflammatory cytokines TNFa, IFN-a/j/y, IL-I-a/p, M-CSF, and GM-CSF can all be secreted by LPSinduced macrophages and microglia and thus may act to potentiate the inflammatory response in an autocrine manner (46, 47) . In addition, they may be secreted by other activated cells and act on macrophages or microglia in a paracrine manner; for example, IL-1 is released by B cells, natural killer cells, neutrophils, endothelial cells (EC), and astrocytes (4). Cytokines derived from macrophages or other cells may in turn regulate the levels of other cytokines; IFN-y enhances macrophage release of TNF-a; IL-1 and TNF-a induce each other's release from EC and macrophages; and IL-I and TNF-a stimulate fibroblasts and EC to release GM-CSF (48) (49) (50) . How these complex networks of signals regulate the secretory capacity of macrophages and microglia is not well understood. We provide evidence that they can regulate the cysteine lysosomal proteases, in particular cathepsin S, which may be important for extracellular action against matrix and basement membrane proteins. Cathepsin S joins the growing list of secretory products of stimulated macrophages and microglia that may act to modulate tissue remodeling.
HSPG has been described as a multi-domain, multifunctional molecule that binds growth factors and extracellular matrix molecules such as type IV collagen, laminin, and fibronectin (14) . Such interactions may result in control of cell proliferation and differentiation. In this study, we have demonstrated that purified recombinant cathepsin S can degrade HSPG derived from Engelbreth-Holm-Swarm tumor, which is similar to HSPG found in the basement membrane of many tissues including skin, liver, blood vessels, and kidney. HSPGs are important low-affinity cellsurface and ECM receptors for bFGF which facilitate bFGF binding to FGF receptors (FGFRs) and promote their dimerization (16) . Perlecan, the large basement membrane HSPG, was previously found to induce high-affinity binding to cells deficient in heparan sulfate and to soluble FGF receptors, and promote mitogenesis and angiogenesis (15) . We (51) (52) (53) . Proteoglycan shedding from cultured cells has been known for a long time, although the specific proteases involved remain elusive (54) . Here we demonstrate a role for secreted cathepsin S in the regulation of bFGFbinding of HSPG in the ECM.
In summary, we have shown that cellular cathepsin levels are negatively regulated in macrophages and microglia in response to LPS and other activating inflammatory cytokines. However, these activating agents are able to stimulate macrophages and microglia to significantly increase their secretion of cathepsin S, which remains active at neutral pH for long duration. Cathepsin S had been shown to process ECM molecules, and here we demonstrate that it also degrades basement membrane HSPG. These observations suggest that it might be involved in the regulation of heparan sulfate interactions with important signaling molecules.
